Labcorp plans laboratory expansion in Japan through BML collaboration

BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 28, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it is enhancing its central laboratory presence and drug development capabilities in Japan through an expansion of CB Trial Laboratory, the central laboratory co-managed by Labcorp Drug Development and BML, a leading Japanese provider of clinical laboratory testing services.

Circuit Clinical and Pottstown Medical Specialists (PMSI) bring clinical research to 180K+ patients across greater northwest Philadelphia region

BUFFALO, N.Y., June 28, 2022 — Following its mission to transform the way patients find, choose, and experience clinical research, Circuit Clinical - one of the nation's fastest-growing research networks - has partnered with Pottstown Medical Specialists (PMSI) - a leading primary care and specialty services physician network - to bring clinical research as a care option close to home for over 180,000 residents across the area's Montgomery and Berks counties. Clinical trial opportunities will be provided by Labcorp, a global life sciences company.

Tigerlily Foundation and Labcorp collaborate to increase clinical trial diversity for women of color

BURLINGTON, N.C. & ALDIE, Va. --(BUSINESS WIRE)--Jun. 24, 2022-- Labcorp , a leading global life sciences company, and Tigerlily Foundation (Tigerlily), a leading breast cancer patient advocacy organization, today announced a new collaboration to increase clinical trial diversity for women of color

Labcorp enhances clinical trial and drug development capabilities through real-world data collaboration with HealthVerity

BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 21, 2022-- Labcorp ® (NYSE: LH), a leading global life sciences company, today announced a new collaboration with HealthVerity , Inc., the leader in Identity, Privacy, Governance, and Exchange (IPGE) for real-world data (RWD), that will expand Labcorp’s comprehensive, end-to-end drug development and clinical trial programs.